Rexahn Pharmaceuticals Inc (NYSE American:RNN)

2.16
Delayed Data
As of 3:59pm ET
 -0.02 / -0.92%
Today’s Change
1.42
Today|||52-Week Range
4.37
+6.93%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close2.18
Today’s open2.18
Day’s range2.12 - 2.19
Volume253,356
Average volume (3 months)395,087
Market cap$67.9M
Data as of 3:59pm ET, 05/24/2018

Growth & Valuation

Earnings growth (last year)-130.00%
Earnings growth (this year)+29.35%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.05

Competitors

 Today’s
change
Today’s
% change
SPHSSophiris Bio Inc+0.04+1.13%
EIGREiger BioPharmaceuti...-0.85-6.09%
NOVNNovan Inc-0.02-0.66%
NBYNovaBay Pharmaceutic...+0.08+3.27%
Data as of 4:00pm ET, 05/24/2018

Financials

Next reporting dateAugust 15, 2018
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$0.00
Annual profit (last year)-$25.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Peter David Suzdak
President &
Chief Financial Officer
Douglas J. Swirsky
Corporate headquarters
Rockville, Maryland

Forecasts